MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, KNSA had -$17,179K decrease in cash & cash equivalents over the period. $33,006K in free cash flow.

Cash Flow Overview

Change in Cash
-$17,179K
Free Cash flow
$33,006K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net income (loss)
18,435 26,371
Depreciation and amortization expense
384 703
Share-based compensation expense
10,144 16,624
Non-cash lease expense
944 1,759
Net amortization of premiums and accretion of discounts on short-term investments
-603 589
Net gain on disposal of property and equipment
43 24
Deferred income taxes
4,227 5,637
Prepaid expenses and other current assets
-2,030 12,195
Accounts receivable, net
19,832 -9,814
Inventory
-6,785 21,817
Other long-term assets
143 -1,975
Accounts payable
-2,728 6,992
Accrued expenses, accrued collaboration expenses and other current liabilities
8,368 9,502
Operating lease liabilities
-760 -1,777
Other long-term liabilities
5,263 7,439
Net cash provided by operating activities
33,677 50,414
Purchases of property and equipment
671 264
Purchases of short-term investments
146,160 129,793
Proceeds from the maturities of short-term investments
84,076 74,633
Net cash used in investing activities
-62,755 -55,424
Proceeds from issuance of class a ordinary shares under incentive award plans and employee share purchase plan
16,252 15,925
Payments in connection with ordinary shares tendered for employee tax obligations
4,353 2,459
Net cash provided by financing activities
11,899 13,466
Net decrease in cash and cash equivalents
-17,179 8,456
Cash and cash equivalents at beginning of period
183,581 -
Cash and cash equivalents at end of period
174,858 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Kiniksa Pharmaceuticals International, plc (KNSA)

Kiniksa Pharmaceuticals International, plc (KNSA)